Hamilelikte retinyl palmitate kullanmaktan kaçınmalı mıyım? | VeriMom
Retinyl palmitate is associated with developmental/teratogenic effects in animal oral studies (rats/rabbits) and is a source of retinoic acid activity; this supports a 'suspected' reproductive hazard rather than a harmonised Category 1 human teratogen classification. The mechanistic basis is well characterized (retinoid → retinoic acid, RAR agonism). For topical cosmetic use systemic exposure is low but measurable; regulatory actions in the EU are moving to limit vitamin A equivalents in cosmetics and require labelling, reflecting concern over systemic exposure. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/8884871/))
ECHA regulatory hazard statements
- •H360
- •H361
- •H361d
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- retinyl palmitate hamilelikte güvenli mi?
- Retinyl palmitate is associated with developmental/teratogenic effects in animal oral studies (rats/rabbits) and is a source of retinoic acid activity; this supports a 'suspected' reproductive hazard rather than a harmonised Category 1 human teratogen classification. The mechanistic basis is well characterized (retinoid → retinoic acid, RAR agonism). For topical cosmetic use systemic exposure is low but measurable; regulatory actions in the EU are moving to limit vitamin A equivalents in cosmetics and require labelling, reflecting concern over systemic exposure. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/8884871/))
- retinyl palmitate emzirirken güvenli mi?
- Mechanism and animal developmental data apply equally to lactation concerns because retinoids can be systemically available and transfer to offspring via milk when internal dose is sufficient; topical use gives low but measurable absorption so breastfeeding exposure is possible though expected to be low for normal cosmetic use. Regulatory guidance and safety reviews therefore treat vitamin A derivatives cautiously in pregnancy/lactation. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/8884871/))
- retinyl palmitate bebek cildi için güvenli mi?
- Do not change hazard or mechanism absent infant‑specific hazard data, but exposure is increased for infants (0–3 yr) because immature skin has higher permeability and greater surface‑area‑to‑weight; therefore exposure score is raised by +1 relative to adults. Animal developmental/teratogenic data indicate intrinsic hazard of the retinoid pathway; topical exposure to infants would warrant caution. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/8884871/))
- VeriMom retinyl palmitate nasıl puanlıyor?
- VeriMom retinyl palmitate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 13/100 (yüksek risk) olarak puanlar.
- Hamilelikte retinyl palmitate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.